AGTC posts quarterly net loss

Applied Genetic Technologies Corporation reported a net loss of $4.2 million, or $0.23 per share, in its second fiscal quarter ended Dec. 31, 2018, compared with a net loss of $5.2 million, or $0.29 per share, in the same quarter a year ago.
Total revenue was $5.9 million for the quarter compared with $4.9 million the previous year, according to a press release.
Research and development expenses totaled $7.6 million, while general and administrative expenses were $3 million.
AGTC had $96.1 million in cash, cash equivalents and investments as of Dec. 31.

Full Story →